according to their prospectus
Osteopore currently generates revenue in Singapore (6%), Malaysia (2%), South Korea (52%), Vietnam (33%) and in other nations (7%)
They focused on China market late 2019.
Given the virus scare, quarantine, and market stress, SP will probably go lower. 52% of the business is south korea which is badly affected by the virus scare. Even home base Singapore is in code orange. I don't think we've bottomed out yet. Eyeing on a better entry point... I like the business idea. looks like a good spec stock
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(16.7%) |
Mkt cap ! $1.830M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.2¢ | 1.0¢ | $42.36K | 3.789M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1701089 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 136370 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| OSX (ASX) Chart |